Correlation Between Bristol Myers and Trevi Therapeutics
Can any of the company-specific risk be diversified away by investing in both Bristol Myers and Trevi Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol Myers and Trevi Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bristol Myers Squibb and Trevi Therapeutics, you can compare the effects of market volatilities on Bristol Myers and Trevi Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol Myers with a short position of Trevi Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol Myers and Trevi Therapeutics.
Diversification Opportunities for Bristol Myers and Trevi Therapeutics
-0.5 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Bristol and Trevi is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and Trevi Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Trevi Therapeutics and Bristol Myers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with Trevi Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Trevi Therapeutics has no effect on the direction of Bristol Myers i.e., Bristol Myers and Trevi Therapeutics go up and down completely randomly.
Pair Corralation between Bristol Myers and Trevi Therapeutics
Considering the 90-day investment horizon Bristol Myers Squibb is expected to generate 0.79 times more return on investment than Trevi Therapeutics. However, Bristol Myers Squibb is 1.27 times less risky than Trevi Therapeutics. It trades about 0.16 of its potential returns per unit of risk. Trevi Therapeutics is currently generating about -0.06 per unit of risk. If you would invest 5,292 in Bristol Myers Squibb on August 25, 2024 and sell it today you would earn a total of 531.00 from holding Bristol Myers Squibb or generate 10.03% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Bristol Myers Squibb vs. Trevi Therapeutics
Performance |
| Timeline |
| Bristol Myers Squibb |
| Trevi Therapeutics |
Bristol Myers and Trevi Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Bristol Myers and Trevi Therapeutics
The main advantage of trading using opposite Bristol Myers and Trevi Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol Myers position performs unexpectedly, Trevi Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Trevi Therapeutics will offset losses from the drop in Trevi Therapeutics' long position.| Bristol Myers vs. Capricor Therapeutics | Bristol Myers vs. Akari Therapeutics PLC | Bristol Myers vs. Soleno Therapeutics | Bristol Myers vs. Bio Path Holdings |
| Trevi Therapeutics vs. Cue Biopharma | Trevi Therapeutics vs. AN2 Therapeutics | Trevi Therapeutics vs. Bioatla | Trevi Therapeutics vs. Spero Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |